DCX Systems Ltd
Q1 FY23 Earnings Call Analysis
Aerospace & Defense
fundraise: No informationcapex: Yesrevenue: Category 3margin: Category 3orderbook: No information
📋orderbook
Current/ Expected Orderbook/ Pending Orders?
- Current order book stands at approximately INR 1,700 crore as of May 2023.
- This order book includes around 60% export orders and 40% domestic orders.
- The orders are scheduled over multiple years, typically spanning two to two and a half years.
- Execution of the order book is planned over FY24 and beyond; it is not expected to be exhausted within a single fiscal year.
- The company is working actively to convert its robust pipeline into confirmed purchase orders (POs).
- No new material POs beyond the existing 1,600+ crore have been received at the time of the call.
- There is confidence in securing good future order pipelines, including potential orders from domestic and global defense OEMs.
- The company emphasizes risk mitigation in both business and financial areas to protect and convert POs into cash flows effectively.
💰fundraise
Any current/future new fundraising through debt or equity?
- No explicit mention of any imminent new fundraising through debt or equity in the provided text.
- The company is managing current borrowings, with gross borrowing reported at INR503 crores as of March 31, 2023.
- Working capital requirements are being met through existing banking credit facilities, mainly packing credits, with strategic advances from customers used as fixed deposits to mitigate interest costs.
- IPO proceeds have been partly reserved for potential technology acquisitions, indicating a preference to use internal resources or IPO funds for expansion rather than immediate fresh fundraising.
- The company is focused on organic growth, improving operational capacity, and technology acquisition but has not disclosed any plans for fresh debt or equity fundraising in FY24 or near term.
🏗️capex
Any current/future capex/capital investment/strategic investment?
- DCX plans a small capex of around INR 4-5 crores to expand its cable and wire harness business, likely in the SEZ or DTH areas.
- No major capex is needed for system integration, as current capacity suffices for the next 3-4 years.
- Recently, INR 35-40 crores was invested in Raneal Advance Systems, with no expected further capex on this front for the next 3-4 years.
- DCX is reserving funds from the IPO to acquire product technology in aerospace and defense, with ongoing discussions involving foreign OEMs from countries like Israel, France, and the US.
- The company aims to become a product company within 1.5 to 2 years through strategic technology acquisitions, though no concrete deals have been signed yet.
📊revenue
Future growth expectations in sales/revenue/volumes?
- The company exhibited strong past growth, scaling from INR 27 crores in 2017 to INR 1,235 crores in FY22 with a 55%+ CAGR.
- FY23 growth slowed to 13%, partly due to global external factors like supply chain constraints and chip shortages.
- Management expects continued revenue growth but refrains from providing specific guidance, citing external uncertainties.
- The current order book (~INR 1,700 crores) is spread over 2–2.5 years, supporting steady execution.
- Export orders constitute about 60% of the order book, with domestic orders about 40%.
- Diversification efforts have reduced dependence on single customers, broadening market opportunities.
- Working capital and inventory management will scale proportionately as turnover grows.
- The company aims to evolve into a product company within 1.5–2 years, likely supporting growth.
- Overall, management remains optimistic but cautious about external market conditions impacting near-term growth.
📈margin
Future growth expectations in earnings/operating earnings/profits/EPS?
- DCX Systems has demonstrated strong historical growth (55% CAGR from INR 27 crores in 2017 to over INR 1,100 crores in FY22).
- FY23 revenue growth was 13%; future growth may depend on external market conditions and supply chain normalization.
- The company plans to expand into PCB manufacturing and product development via technology transfer, aiming to evolve into a technology-driven product company within 1.5 to 2 years.
- EBITDA margins are expected to improve but likely remain below teenage percentage levels; EMS business margins typically range around 12-14%.
- Increased working capital needs are anticipated with revenue growth, but advances from customers will provide some cash flow support.
- Management is optimistic about reasonable top-line growth and proportional EBITDA and bottom-line improvements over the next 1-2 years.
- Supply chain disruptions are easing, enabling better execution and growth potential in FY24.
